Clinical Trials Insight: 700040591
Phase of Trial: Phase II
Latest Information Update: 11 Jun 2010
At a glance
- Drugs Tesetaxel (Primary)
- Indications Cancer; Gastrointestinal stromal tumours; Nasopharyngeal cancer; Solid tumours; Uterine cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Genta
- 11 Jun 2010 According to an ASCO abstract, twenty-six patients have been treated to date, and accrual is continuing.
- 07 Jun 2010 Results presented at the ASCO 2010, according to a Genta media release.
- 26 Feb 2010 Status changed from recruiting to completed, according to a Genta media release.